Cary Green, MHA
Cary Green joined SUNRx in July 2016 as Director of Sales and has a master’s in health administration with over 25 years of experience in pharmaceuticals, biotechnology, hospital administration and home care. Cary began working in 340B within the pharmaceutical industry in 1993 to implement and manage 340B contracts with eligible entities, ensure compliance with Medicare best price, develop audit procedures to uncover diversion and later negotiating exclusive contracts with 340B academic DSH hospitals.
In a variety of roles with SUNRx, Trish has served hospital clients with Pharmacy/Hospital Development, 340B Program Management, 340B Program Implementation and Training.
She also managed top chain pharmacy relationships for SUNRx, such as Tops Supermarkets, Ridley’s, Thrifty White, Raley’s, Fruth and Bi-Lo Corporation. Trish’s 340B program experience is coupled with 14 years of advertising and marketing experience with the Philadelphia Media Network, AccuWeather and Davis Advertising.
Todd Nova, a Shareholder of Hall, Render, Killian, Heath & Lyman, focuses on health law issues for health care providers across the country including integrated health care systems, pharmacies (retail, specialty and institutional), hospitals, group purchasing organizations and physician group practices.
This work includes an emphasis on matters affecting the sourcing, delivery, dispensing and reimbursement of pharmaceuticals, including the 340B drug discount program, state and federal government payor issues (fee for service and managed care), false claims and anti-kickback laws, collaborative practice models, health care licensing, distribution and sourcing agreements (group and direct purchasing) in addition to private payor issues. Todd’s work also includes advising providers responsible for caring for underserved and rural populations.
Delphine P. O’Rourke
Delphine O'Rourke serves as Managing Partner of the Philadelphia office of Hall, Render, Killian, Heath & Lyman. Delphine concentrates her practice on representing national health systems and advises clients in the areas of strategy, general counsel services and government relations & health policy. She serves as in-house Chief Legal Officer for a national health system's East Coast hospitals in Connecticut, New York, Maryland and the District of Columbia. Additionally, she regularly speaks to stakeholders on a variety of health care issues that affect hospitals and hospital systems including fraud and abuse enforcement, health care reform and the role of generative boards of directors.
Terri Cathers, PharmD
Dr. Cathers is the Director of Pharmacy for the Pennsylvania Fee-For-Service Medicaid Program since 2004.
Dr. Cathers earned a Doctor of Pharmacy degree in 1997 from the University of Maryland’s School of Pharmacy. Dr. Cathers has commercial managed care pharmacy program management experience from both the Pharmacy Benefit Manager (PBM) and the health plan perspective.
Terri began her experience in the government sector in November 2004 and since that, time has implemented a comprehensive pharmacy program for the PA Department of Human Services’ Medical Assistance Programs.
Ted Slafsky is the President and Chief Executive Officer for 340B Health, a nonprofit organization of more than 1,300 hospitals and health systems participating in the federal 340B drug pricing program.
Mr. Slafsky oversees a team of government relations experts, attorneys and pharmacists who advocate on behalf of member hospitals and provide guidance on how to utilize the 340B drug discount program. Under Mr. Slafsky's leadership, the organization has grown from 50 member hospitals to more than 1,200 and 340B Health's staff has increased from just two employees to over 30 staff and consultants.
Mr. Slafsky is also Founder and Editor-in-Chief of 340B Informed (formerly the Drug Discount Monitor), the first and only publication to focus specifically on the 340B program. He also oversees 340B Health’s other communications resources including the members-only electronic news service, the 340B Health Bulletin. Mr. Slafsky is a frequent contributor to various national publications and is considered one of the nation’s leading experts on pharmaceutical and safety net health care matters.
Amanda Nagrotsky is the Assistant Counsel for 340B Health, a nonprofit organization of more than 1,300 hospitals and health systems participating in the federal 340B drug pricing program.
Ms. Nagrotsky works with a team of lawyers and government relations staff on regulatory, legislative and legal matters related to the 340B program. She educates member hospitals on 340B compliance and implementation and informs them of program developments. Additionally, Ms. Nagrotsky conducts research and prepares legal analyses and advocacy documents on various 340B issues.
Christopher Giese became Chief Executive Officer of eAudit Solutions, Inc. (eAS), in October 2016. The company was founded in 2005, is headquartered in Grapevine Texas, and has hundreds of customers across the country. eAS provides Split Billing and Inventory Management services to 340B covered entities, and Invoice Analysis, which identifies and corrects incorrectly priced drugs.
Prior to eAudit Solutions, Chris was Vice President for Tennessee Hospital Association (THA). In that role, he developed programs for member hospitals in pharmaceutical distribution and 340B retail networks, and led the development of THA’s strategies for population health management. Chris also oversaw THA’s 340B program, including its owned GPO compliance, advocacy and policy management, and 340B compliance education for member hospitals.
Chris earned his MBA from McKendree University in Louisville, KY. He is a Fellow of American College of Healthcare Executives (FACHE).